rs5916352

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181332.3(NLGN4X):​c.-306+4214G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.434 in 110,468 control chromosomes in the GnomAD database, including 8,673 homozygotes. There are 13,706 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.43 ( 8673 hom., 13706 hem., cov: 22)

Consequence

NLGN4X
NM_181332.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.493

Publications

2 publications found
Variant links:
Genes affected
NLGN4X (HGNC:14287): (neuroligin 4 X-linked) This gene encodes a member of the type-B carboxylesterase/lipase protein family. The encoded protein belongs to a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. The encoded protein interacts with discs large homolog 4 (DLG4). Mutations in this gene have been associated with autism and Asperger syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
NLGN4X Gene-Disease associations (from GenCC):
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • autism, susceptibility to, X-linked 2
    Inheritance: XL Classification: STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_181332.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.685 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181332.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLGN4X
NM_181332.3
MANE Select
c.-306+4214G>C
intron
N/ANP_851849.1Q8N0W4-1
NLGN4X
NM_001282145.2
c.-613+4214G>C
intron
N/ANP_001269074.1Q8N0W4-1
NLGN4X
NM_001282146.2
c.-306+2553G>C
intron
N/ANP_001269075.1Q8N0W4-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLGN4X
ENST00000381095.8
TSL:1 MANE Select
c.-306+4214G>C
intron
N/AENSP00000370485.3Q8N0W4-1
NLGN4X
ENST00000275857.10
TSL:1
c.-306+3362G>C
intron
N/AENSP00000275857.6Q8N0W4-1
NLGN4X
ENST00000381092.1
TSL:2
c.-613+4214G>C
intron
N/AENSP00000370482.1Q8N0W4-1

Frequencies

GnomAD3 genomes
AF:
0.433
AC:
47847
AN:
110417
Hom.:
8666
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.693
Gnomad AMI
AF:
0.439
Gnomad AMR
AF:
0.355
Gnomad ASJ
AF:
0.285
Gnomad EAS
AF:
0.177
Gnomad SAS
AF:
0.281
Gnomad FIN
AF:
0.370
Gnomad MID
AF:
0.397
Gnomad NFE
AF:
0.340
Gnomad OTH
AF:
0.416
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.434
AC:
47901
AN:
110468
Hom.:
8673
Cov.:
22
AF XY:
0.419
AC XY:
13706
AN XY:
32746
show subpopulations
African (AFR)
AF:
0.693
AC:
20987
AN:
30282
American (AMR)
AF:
0.355
AC:
3707
AN:
10443
Ashkenazi Jewish (ASJ)
AF:
0.285
AC:
752
AN:
2634
East Asian (EAS)
AF:
0.177
AC:
618
AN:
3489
South Asian (SAS)
AF:
0.283
AC:
748
AN:
2646
European-Finnish (FIN)
AF:
0.370
AC:
2151
AN:
5811
Middle Eastern (MID)
AF:
0.404
AC:
86
AN:
213
European-Non Finnish (NFE)
AF:
0.340
AC:
17939
AN:
52772
Other (OTH)
AF:
0.410
AC:
618
AN:
1506
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
877
1754
2632
3509
4386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.379
Hom.:
2485
Bravo
AF:
0.449

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
7.1
DANN
Benign
0.63
PhyloP100
0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs5916352;
hg19: chrX-6142368;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.